Involvement of C-MYC and max in CNS β-endorphin modulation of hepatic ornithine decarboxylase responsiveness to insulin in rat pups

Life Sciences

Volumn 64, Issue 5, 1998, Pages

  Bartolome, Jorge V ^a   Wang, Shiying ^a   Schanberg, Saul M ^a   Bartolome, Maria B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

c myc mRNA; Hepatic ODC; Insulin; max mRNA; endorphin

Indexed keywords

BETA ENDORPHIN; INSULIN; MESSENGER RNA; MYC PROTEIN; ORNITHINE DECARBOXYLASE; POLYADENYLATED RNA; SODIUM CHLORIDE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIVER; NEWBORN; NONHUMAN; ONCOGENE C MYC; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0033601480     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00572-4     Document Type: Article

References (24)

1. 1. C. Amin, A.J. Wagner and N. Hay, Mol. Cell. Biol. 13 383-390 (1993).
2. 2. D.S. Askew, R.A. Ashmun, B.C. Simmons and J.L. Cleveland, Oncogene 6 1915-1922 (1991).
3. 3. N.K. Banskota, R.Taub, K. Zellner, P. Olsen and G.L. King, Diabetes 38 123-129 (1989).
4. 4. J.V. Bartolome, M.B. Bartolome, L.A. Daltner, C.J. Evans, J.D. Barchas, C.M. Kuhn and S.M. Schanberg, Life Sci. 38 2355-2362 (1986).
5. 5. J.V. Bartolome, M.B. Bartolome, B.A. Lorber and S.M. Schanberg, Mol. Cell. Neurosci. 2 1-5 (1991).
6. 6. J.V. Bartolome, M.B. Bartolome, B.A. Lorber, S.J. Dileo and S.M. Schanberg, Neuroscience 40 289-294 (1991).
7. 7. J.V. Bartolome, S. Wang and M.B. Bartolome, Mol. Brain Res. 33 149-156 (1995).
8. 8. C. Bello-Fernandez, G. Packham and J.L. Cleveland, Proc. Natl. Acad. Sci. USA 90 7804-7808 (1993).
9. 9. S. Berberich, N. Hyde-DeRuyescher, P. Espenshade and M. Cole, Oncogene 7 775-779 (1992).
10. 10. E.M. Blackwood and R.N. Eisenman, Science 257 1211-1217 (1991).
11. 11. E.M. Blackwood, B. Lüscher and R.N. Eisenman, Genes Dev. 6 71-80 (1992).
12. 12. P. Chomcynski and N. Sacchi, Analyt. Biochem. 162 156-159 (1987).
13. 13. T.J. Haley and W.G. McCormick, Br. J. Pharmacol. 12 12-15 (1957).
14. 14. N.J. Hickok, J. Wahlfors, A. Crozat, M. Halmekytö, L. Alhonen, J. Jänne and O.A. Jänne, Gene 93 257-263 (1990).
15. 15. N.L. Greer, S.M. Schanberg and J.V. Bartolome, Pediatr. Res. 29 182-186 (1991).
16. 16. A. Katz and Kahana, J. Biol. Chem. 263 7604-7609 (1988).
17. 17. H. Land, L.F. Parada and R.A. Weinberg, Nature 304 596-602 (1983).
18. 18. A.E. Pegg and P.P. McCann, Am. J. Physiol. 243 C212-C221 (1982).
19. 19. A. Peña, C.D. Reddy. S. Wu, N.J. Hickok, E.P. Reddy, G. Yumet, D.R. Soprano and K.J. Soprano, J. Biol. Chem. 268 27277-27285 (1993).
20. 20. D. Sakamuro, K.J. Elliot, R. Wechsler-Reya and G.C. Prendergast, Nat. Genet. 14 69-77 (1996).
21. 21. T.A. Slotkin and J.V. Bartolome, Brain Res. Bull. 17 307-320 (1986).
22. 22. H. van Steeg, C.T.M. van Oostrom, H.M. Hodemaekers and C.F. van Kreyl, Gene 93 249-256 (1990).
23. 23. C.W. Tabor and H. Tabor, Ann. Rev. Biochem. 53 749-790 (1984).
24. 24. S. Wu, A. Peña, A. Korcz, D.R. Soprano and K. J. Soprano, Oncogene 12 621-629 (1996).